Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Antimicrob Agents Chemother ; 18(5): 798-806, 1980 Nov.
Article in English | MEDLINE | ID: mdl-7004349

ABSTRACT

Mutants resistant to the 2-deoxystreptamine aminoglycosides hygromycin B and gentamicin were analyzed biochemically and genetically. In hygromycin B-resistant strains, ribosomal alterations were not detectable by electrophoretic or genetic experiments. Rather, as was demonstrated for one strain in detail, resistance to this drug seems to be the consequence of several mutations, each impairing drug accumulation, namely of a deletion of a gene close to the proC marker which potentiates the effect of a second mutation in the unc gene cluster. Three mutants resistant to gentamicin which were previously demonstrated to harbor an altered ribosomal protein, L6, were shown in addition to contain unc. Both the unc and the ribosomal mutation greatly impair the drug accumulation ability of the mutants. Further evidence for the direct effect of ribosomal mutations on the uptake of aminoglycosides was obtained with strains that possess ribosomes with increased affinity for dihydrostreptomycin. Dihydrostreptomycin transport by these cells is greatly stimulated; thus, the hypersensitivity of these mutants is caused by increased binding affinity for dihydrostreptomycin and its secondary effect on the uptake process. Experiments were also performed on the biochemical basis of the third phase of aminoglycoside transport (acceleration phase). The condition for its onset is that ribosomes are active in protein synthesis irrespective of whether the proteins synthesized are functional. This, and the failure to observe the synthesis of new proteins upon the addition of aminoglycosides, do not support the view of autoinduction of a cognate or related transport system.


Subject(s)
Anti-Bacterial Agents/metabolism , Escherichia coli/metabolism , Ribosomes/metabolism , Aminoglycosides/metabolism , Anti-Bacterial Agents/pharmacology , Bacterial Proteins/biosynthesis , Drug Resistance, Microbial , Escherichia coli/drug effects , Escherichia coli/genetics , Leucine/metabolism , Mutation
2.
J Bacteriol ; 143(3): 1135-41, 1980 Sep.
Article in English | MEDLINE | ID: mdl-6997265

ABSTRACT

Mutations leading to borrelidin resistance in Escherichia coli by overproduction of threonyl-transfer ribonucleic acid synthetase were anaylzed genetically. The regulatory mutations were closely linked to the treonyl-transfer ribonucleic acid synthetase structural gene (thrS), located clockwise to it. The mutation that causes the threefold-increased enzyme level was more distant from thrS than the mutation responsible for the ninefold overproduction. Both mutations were cis dominant in merodiploid strains, indicating that they affected promoter-operator-like control elements. Overproduction was restricted to threonyl-transfer ribonucleic acid synthetase and was not observed for the products of genes neighboring thrS (e.g., infC, pheS, pheT, and argS), providing evidence that thrS is transcribed singly and that gene amplificationis not a likely basis for increased thrS experession.


Subject(s)
Amino Acyl-tRNA Synthetases/genetics , Anti-Bacterial Agents/pharmacology , Escherichia coli/genetics , Genes, Regulator , Genes , Threonine-tRNA Ligase/genetics , Chromosome Mapping , Drug Resistance, Microbial , Escherichia coli/drug effects , Genetic Linkage , Mutation , Threonine-tRNA Ligase/biosynthesis
SELECTION OF CITATIONS
SEARCH DETAIL
...